Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Type 2 Diabetes
Interventions
DEVICE

Professional flash glucose mornitoring

Subjects will use Professional flash glucose mornitoring once a month for 3 months.

DEVICE

Personal flash glucose mornitoring

Subjects will use Personal flash glucose mornitoring once a month for 3 months.

Trial Locations (1)

210012

Nanjing First Hospital, Nanjing

All Listed Sponsors
collaborator

Wuxi Hospital of Traditional Chinese Medicine

UNKNOWN

collaborator

Wuxi People's Hospital Affiliated to Nanjing Medical University

UNKNOWN

collaborator

Huai'an Second People's Hospital and the Affiliated Huai'an Hospital of Xuzhou Medical University

UNKNOWN

collaborator

The Affiliated Suqian First People's Hospital of Nanjing Medical University

UNKNOWN

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT04847219 - Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter